David J. Benjamin, MD retweeted
Cancer trials enroll more women but rarely compare outcomes by sex, leaving safety gaps and urging equity-focused study design. 🔬
📝 @DavidBenjaminMD (@hoaghealth) writes for Targeted Oncology: targetedonc.com/view/more-ca…
#ClinicalTrials #HealthEquity #CancerResearch #Oncology
David J. Benjamin, MD retweeted
🧵 1/
Proud to finally share a paper that took a great deal of effort to write and get published.
A global survey sent to 600+ uro-oncologists, with 201 responses from over 30 countries, exploring real-world use of enfortumab vedotin + pembrolizumab (EV-P) in metastatic urothelial carcinoma. 😊 One of the largest initiatives of its kind to date. 🌍
academic.oup.com/oncolo/adva…
@UroDocAsh @OncoBellmunt @ProfSyedHussain @AlisonBirtle @raymanneh @dmukherji @amerseburger @DrIacovelli @giannatempopatr @DrYukselUrun @BourlonMaite @cdanicas @DrFelixGuerrero @mflazzaro_gu @ravikanesvaran @DrBenTran @OncoAlert @Larvol @_SEOM @myESMO @urotoday
David J. Benjamin, MD retweeted
Replying to @DavidBenjaminMD
@DavidBenjaminMD of @hoaghealth, discusses how he uses real-world data to supplement clinical trial results in urothelial carcinoma.
Read the full article here: hubs.li/Q03rq-MJ0
David J. Benjamin, MD retweeted
Real-World Data Help Fill the Gaps Left by Clinical Trial Results in Urothelial Carcinoma @DavidBenjaminMD #blcsm hubs.li/Q03rkD3C0
David J. Benjamin, MD retweeted
RWE is crucial for our daily clinical practice! What insightful discussions on mUC treatments! Balancing QoL with efficacy is the key! @drenriquegrande @DavidBenjaminMD
David J. Benjamin, MD retweeted
Replying to @TheLancetOncol
@TheLancetOncol Comment: As cancer therapies evolve, sexual & reproductive #Toxicity remains underreported. Experts like @DavidBenjaminMD call for integrating #Oncofertility into routine care—especially for younger patients. bit.ly/4lwGBET #ReproductiveHealth
David J. Benjamin, MD retweeted
🧨Great to be editors pick in @TheLancetOncol this month for our comment....highlighting Sexual health and reproductive toxicity from cancer therapies
thelancet.com/journals/lanon…
@DavidBenjaminMD @ImperialSandC @pash22 @SullivanProf @oncology_bg @darioT_ @SuyogCancer @BMJOncology
David J. Benjamin, MD retweeted
One of the highlights of #SoCalGU25 was our inaugural poster session. Congrats to our poster sessions winners, #DrFarzadTeymouri, @gonzales_neekz & @MazyarZahir - equally deserving are their mentors @ArashRezazadeh6 @UCIrvine, @DavidBenjaminMD @hoaghealth, @EdwinPosadasMD, @jgong15 @CSCancerCenter & @siadaneshmand @USC_Urology. Please mark your calendar for Feb 13, 2026 for #SoCalGU26!
David J. Benjamin, MD retweeted
Our paper is out: I found this interesting
Some cancers celebs are more likely to admit to having than others. Above the line is over represented reporting in media.
Does reading an article about a public figure with cancer leave you with more uncertainty than clarity?
In @myESMO Real World Data and Digital Oncology, we review news articles about public figures with cancer from 2010 to 2020.
Our study found that most articles lack pertinent details (e.g. type, prognosis, treatment, etc.) on cancer care. Understandably, public figures may choose not to disclose personal aspects of their cancer care.
The lack of details and general uncertainty about cancer in these public figures may ultimately lead to more fear and anxiety among readers.
CC: @VPrasadMDMPH @vkprasadlab @ArashRezazadeh6
Link (full text): esmorwd.org/article/S2949-82…
David J. Benjamin, MD retweeted
State of the Genitourinary Medical Oncology Workforce in the United States, 2024. Presentation by @DavidBenjaminMD @hoaghealth. #GU25 written coverage by @zklaassen_md @GACancerCenter > bit.ly/4k1Mqtd @ASCO
David J. Benjamin, MD retweeted
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physicians @ProfSyedHussain @ravikanesvaran @AlisonBirtle @DavidBenjaminMD @giannatempopatr @OncoAlert - Cancer Treatment Reviews cancertreatmentreviews.com/a…
David J. Benjamin, MD retweeted
Looking forward to reviewing this editorial. Timely since TROPiCS04 paper coming very soon, stay tuned :-)
@tompowles1 @Uromigos @y_loriot @DrScottTagawa @OncoBellmunt @cnsternberg @BladderCancerUS @JoshMeeks @montypal @brian_rini @shilpaonc @apolo_andrea @AbhiTrip87 @OncoAlert
Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?
In @EurUrolOncol, we discuss the potential roles of G-CSF, dosing approaches, and differences in patient population compared to the TROPHY-U-01 trial.
Link: authors.elsevier.com/a/1kUbL…
David J. Benjamin, MD retweeted
Amazing piece of work by @DavidBenjaminMD, @DrRanaMcKay and colls. with impact in daily practice: urachal tumors approach should be based on colorrectal cancer schemes rather than bladder. I would love to see insights of activity of EV or ICIs in this scenario vs FOLFOX or FOLFIRI. @OncoAlert @NatureCancer
rdcu.be/d6A9B
David J. Benjamin, MD retweeted
Announcing #SoCalGU25, which will be held on February 28, 2025. This consortium of GU #oncology investigators bridges efforts from @cityofhope, @UCIrvine, @UCLAHealthJCCC, @CSCancerCenter, @UCSDCancer, @uscnorris & other #SoCal institutions.
Last year, our registration filled virtually overnight. This year we have a larger venue & a terrific “external reviewer” - @AndreaNecchi.
Many thanks to my consortium cofounder @siadaneshmand, as well as @DrRanaMcKay, @YuWeiChenMD, @DavidBenjaminMD, @TDorffOnc, @WesleyYipMD, @arafflemd, @KidneyCancerDoc, @ArashRezazadeh6, @jgong15, @DrTylerStewart, @AbhiTrip87, @mar_nataliya & others who have contributed greatly to the groups success!
If you need info or would like to support, please reach out via DM.
David J. Benjamin, MD retweeted
Just out @DavidBenjaminMD and I explain how inadequate staging and excess scans create false impressions of recent drugs
kwnsfk27.r.eu-west-1.awstrac…
David J. Benjamin, MD retweeted
It is critical for individuals with cancer as well as family members and caregivers to be cognizant that previous exposures to cancer through films are unlikely to be realistic depictions of modern-day cancer and its curability and treatment. ascopubs.org/doi/10.1200/OP.…
David J. Benjamin, MD retweeted
🔬 MLS IRVINE Updates in Cancer Therapies 🔬
Join us for a comprehensive review of the 2024 ASCO & ESMO Annual Meetings!
Saturday, October 26, 2024
👉 Register Now! - shorturl.at/CezXl
@CParkMD @PGrivasMDPhD @jgong15 @ArashRezazadeh6 @DavidBenjaminMD – at Irvine, CA
David J. Benjamin, MD retweeted
A review of vitamin use for the prevention or treatment of #ProstateCancer
@DavidBenjaminMD
doi.org/10.1111/bju.16398
David J. Benjamin, MD retweeted
The Fact and Fiction in Hollywood's Cancer Narratives @DavidBenjaminMD #HollywoodCancer #MovieMyths #FilmIndustry ow.ly/cije50RYQzQ
David J. Benjamin, MD retweeted
Our new paper is just out
Do cardiovascular and anti-inflammatory drugs work when repurposed for cancer?
@DavidBenjaminMD
Spoiler alert & see the next few tweets
THESE DRUGS DON'T WORK
b/c repurposing drugs that are not active is unwise
AI won't help
dx.doi.org/10.1002/cam4.7049

































